Wed, Aug 27, 2014, 12:51 PM EDT - U.S. Markets close in 3 hrs 9 mins


% | $
Quotes you view appear here for quick access.

Stryker Corporation Message Board

arlo301 1 post  |  Last Activity: Jun 11, 2014 3:04 PM Member since: Apr 30, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Any comments on the article below??

    Stem Cells Treat Multiple Sclerosis in Mice
    Human embryonic stem cells — the body’s powerful master cells — might be useful for treating multiple sclerosis, researchers reported Thursday.

    A team has used cells taken from frozen human embryos and transformed them into a type of cell that scientists have hoped might help treat patients with MS, a debilitating nerve disease.

    Mice with an induced version of MS that paralyzed them were able to walk freely after the treatment, the team at Advanced Cell Technology reported.

    The cells appeared to travel to the damaged tissues in the mice, toning down the mistaken immune system response that strips the fatty protective layer off of nerve calls. It’s that damage that causes symptoms ranging from tremors and loss of balance to blurry vision and paralysis.

    These embryonic stem cells were carefully nurtured to make them form a type of immature cell called a mesenchymal stem cell. These cells worked better to treat the mice than naturally developed mesenchymal stem cells taken directly from bone marrow, the team wrote in the journal Stem Cell Reports, published by the International Society for Stem Cell Research.

    Lanza says human trials are many months away, but he thinks it will not be necessary to use controversial cloning technology to make perfectly matched human embryonic stem cells to treat patients.

    Sentiment: Hold

82.50-0.35(-0.42%)12:50 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.